Cipla Limited logo

Cipla Limited Investor Relations Material

Cipla Limited develops, manufactures, and markets pharmaceuticals products in India, the United States, South Africa, and internationally. It offers active pharmaceutical ingredients (APIs) and intermediates that comprise anesthetics/sedatives; analytical reference standards; antiretrovirals/antiretroviral intermediates; anticancer/oncology related APIs and intermediates; cardiovascular; dermatological, hair fall control drugs; diabetology; erectile dysfunction drugs; gastroenterology; malaria treatment drugs; musculoskeletal disorders related APIs and intermediates; nephrology-urology-anti-urolithiatic products; nepirology-urology-anti-urolithiatic products; nutritional supplements/vitamins/minerals/trace elements and herbal extracts for human health care products, as well as APIs for cosmetics industries. The company was incorporated in 1935 and is headquartered in Mumbai, India

Latest company events

Ticker symbol

CIPLA

Country

India

About the company

https://www.cipla.com/

Dig deeper into the Cipla Limited fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot